The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New data package for chemical resistant coatings

3 May 2022 07:00

RNS Number : 9548J
Applied Graphene Materials PLC
03 May 2022
 

Reach - non-regulatory announcement

3 May 2022

 

AGM launches new application package for chemical resistant graphene enhanced coatings

AGM Graphene Nanoplatelets Outperform Traditional Protective Additives in Latest Testing

 

Applied Graphene Materials (LSE:AGM), the producer of specialty graphene nanoplatelet dispersions, has launched a new performance data package demonstrating that its graphene nanoplatelet dispersions product range can achieve high levels of protection from harsh chemicals when used in coatings applications. This opens up a new market for AGM's products, where higher-performance graphene-enhanced paints and coatings can effectively protect a substrate against chemicals in highly aggressive environments.

 

Chemical permeation is a major issue in the protective coatings market. Prolonged contact, from full submersion, splashes, spills and fumes, with a range of chemical substances can lead to visual discolouration, gloss reduction, and blistering, all of which can have a negative impact on coating performance. As a result, coatings manufacturers strive to develop surface protection systems that can resist chemicals and protect the substrate from contamination.

 

In comprehensive testing AGM has now demonstrated superior performance of its graphene nanoplatelet dispersions in a range of immersed chemical applications, from acid to alkali. The highly effective graphene technology performs extremely well compared with conventional materials used in the industry at substantially lower loading levels, enabling the formulator to have far greater flexibility with their products and application scope. Protective coatings with comparable additives are used in a range of industries for applications such as chemical tank linings, linings of pipes for transporting chemicals, floor coatings in chemical environments and structural steelwork coatings. AGM also anticipates that the application could be suitable for composite materials often used in this space.

 

AGM's Genable graphene nanoplatelet dispersion technology has already been proven to deliver significant anti-corrosion performance advantages for metallic surfaces in harsh environments, as has been demonstrated with a number of customer product launches. The latest chemical resistance application offering gives its customers in the coatings sector further scope to innovate and develop new products which perform and stand out.

 

Adrian Potts, Chief Executive Officer of AGM, said:

 

"AGM's innovation team have done an outstanding job at demonstrating graphene nanoplatelet materials as a highly effective additive in coatings technology. Using our know-how to disperse graphenes to achieve consistent, reliable performance gains, we are able to bring this new application to market with solid data to support its launch. We know graphene works extraordinarily well in anti-corrosion applications and coatings innovators now have broader scope to integrate a graphene solution into a wider product range. I very much look forward to the technology development being presented through our distributor network and the prospect of strong uptake in its application across a range of opportunities."

 

 

END

 

 

For further information, please contact:

 

Applied Graphene Materials +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

 

Singer Capital Markets +44 (0) 207 496 3000

Peter Steel / Amanda Gray

 

Allenby Capital Limited +44 (0) 203 328 5656

Nick Athanas / Liz Kirchner (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Hudson Sandler +44 (0) 207 796 4133

Nick Lyon / Emily Dillon

 

 

Notes to Editors

 

 

Applied Graphene Materials - For the last decade, AGM has been at the forefront of harnessing the possibilities of graphene. Founded originally by Professor Karl Coleman, the Group has grown from an academic idea from Durham University to a world leader in the development and application of graphene nanoplatelet dispersions for customers in the coatings, composites and functional materials sectors.

 

The Group utilises its proprietary bottom-up manufacturing process to produce high purity graphene nanoplatelets. Its expertise in dispersion chemistry enables AGM to create optimised, stable and easy to handle dispersions that customers use in real-world industrial products. AGM's unique approach enables industries to fully realise the potential of graphene in a simple, safe and easy to formulate way. 

 

AGM, based at the Wilton Centre on Teesside, was admitted to AIM in November 2013, raising £11 million. The Group successfully raised £8.5m in January 2016, £9.8m in November 2017 and a further £6m gross in January 2021. The Group's shares are also cross-traded on OTCQX in the United States. As a result of the funding support and its industry leading technology platform, AGM has been able to develop a significant sales distribution network covering Europe, North America and Asia. The Group continues to work closely with industrial partners, and has seen the successful launch of numerous commercial products enhanced by its Graphene Dispersions.

https://www.appliedgraphenematerials.com/

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFERSLIAFIF
Date   Source Headline
17th Dec 20197:00 amRNSAGM Statement
30th Oct 20193:48 pmRNSDirector/PDMR Shareholding (correction)
30th Oct 20192:02 pmRNSDirector/PDMR Shareholding
30th Oct 20197:00 amRNSCustomer product launched via leading UK retailer
21st Oct 20193:30 pmRNSAGM presents to investors in Beijing
16th Oct 20197:00 amRNSAnnual Results
9th Oct 20192:00 pmRNSOperational update
3rd Oct 20197:00 amRNSAGM develops composite applications for space
30th Sep 201911:30 amRNSNotice of Annual Results
10th Sep 201912:00 pmRNSAGM to present at technical & investor conferences
5th Aug 20194:41 pmRNSSecond Price Monitoring Extn
5th Aug 20194:36 pmRNSPrice Monitoring Extension
5th Aug 20192:05 pmRNSSecond Price Monitoring Extn
5th Aug 20192:00 pmRNSPrice Monitoring Extension
31st Jul 20197:00 amRNSIssue of share options to Directors
10th Jul 20197:00 amRNSAGM advances applications for water-based coatings
9th Jul 201912:20 pmRNSNew Coatings Product Launch
3rd Jun 20197:00 amRNSAGM sign distribution agreement with Carst&Walker
30th May 20197:00 amRNSAGM to showcase Aerospace composites at NATEP
23rd May 20199:37 amRNSAGM signs distribution agreement with CAME Srl
17th May 20197:00 amRNSAGM secures patent in strategic territory
3rd Apr 20197:00 amRNSInterim Results
21st Mar 20197:00 amRNSAGM to attend Corrosion 2019 Conference & Expo
21st Mar 20197:00 amRNSNotice of Interim Results
14th Mar 20197:24 amRNSAGM to Present at European Coatings Show
7th Mar 201911:05 amRNSSecond Price Monitoring Extn
7th Mar 201911:00 amRNSPrice Monitoring Extension
6th Mar 201910:34 amRNSAppointment to the NGA's Industry Council
28th Feb 201911:43 amRNSBreakthrough anti-corrosion graphene technology
31st Jan 20194:58 pmRNSIssue of share options to Directors
21st Jan 201912:00 pmRNSDirector/PDMR Shareholding
15th Jan 20192:05 pmRNSSecond Price Monitoring Extn
15th Jan 20192:00 pmRNSPrice Monitoring Extension
10th Jan 201912:26 pmRNSHolding(s) in Company
18th Dec 20184:33 pmRNSResult of AGM
18th Dec 20187:00 amRNSAGM Statement
13th Dec 20182:05 pmRNSSecond Price Monitoring Extn
13th Dec 20182:00 pmRNSPrice Monitoring Extension
18th Oct 20187:00 amRNSFinal Results
9th Oct 20188:23 amRNSBoard Appointment
12th Sep 20184:40 pmRNSSecond Price Monitoring Extn
12th Sep 20184:35 pmRNSPrice Monitoring Extension
12th Sep 20182:05 pmRNSSecond Price Monitoring Extn
12th Sep 20182:00 pmRNSPrice Monitoring Extension
28th Aug 20182:17 pmRNSNotice of Annual Results
1st Aug 20187:00 amRNSBoard Change
29th Jun 201810:19 amRNSBoard Changes
22nd May 20184:40 pmRNSSecond Price Monitoring Extn
22nd May 20184:35 pmRNSPrice Monitoring Extension
22nd May 20187:00 amRNSJames Briggs Commercial Agreement & Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.